Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
NEW YORK, Nov. 15, 2017 -- As NFL football season delivers high-impact hits week after week, Leonard Marshall isn’t letting the NFL off the hook with his latest challenge.
|
|||||
“We need to get rid of the old guard [in the NFL],” he told Newsweek in it's special edition covering cannabis.
Current NFL players who don’t want to risk testing positive on drug tests that don’t differentiate between THC and CBD are waiting for the NFL to approve CBD for its anti-inflammatory and neuroprotective properties.
“We need something like a panel talking to players and ex-players about CBD products that might replace the drugs players get now,” he continues.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2662c5a0-cda0-47b2-9c1a-2ad2b9cda01c
Marshall has often said some of his motivation is to “save lives,” of former players like himself who are subjected to repeated head trauma. As Newsweek reports, head trauma is responsible for ruining the lives of many former NFL players blamed on the suicides of numerous NFL players including Aaron Hernandez’s last spring and famously, Junior Seau.
Marshall, who recently made headlines as the first CBD advocate to receive a NFL Hall of Fame nomination after he announced he is donating his brain to CTE research, played for the New York Giants and the New Jersey Jets during his storied career which earned him two Super Bowl championships.
Marshall first started using CBD in 2013 after his CTE diagnosis, “I started changing—in the role of a husband and provider—due to the aftermath of head trauma,” he stated. Marshall’s recent CTE video diary has received almost 30,000 views to date.
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products in 27 countries globally including United States, Japan, Puerto Rico, Brazil and throughout Europe. More information available at Elixinol.com.
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]
